Cleerly, Inc., a digital healthcare company focused on AI-driven heart disease diagnosis, has announced continued strong scientific evidence supporting the clinical utility of its products, detailing a study published online in the European Heart Journal Cardiovascular Imaging.
Thorofare Capital provided investment management firm Harrison Street with $125.9 million in financing for the acquisition of eight Class A clinical medical facilities.